dc.contributor
[Batlle M] Department of Surgery, Hospital General Granollers, Universitat Autònoma de Barcelona, Barcelona, Spain. [Badia JM] Department of Surgery, Hospital General Granollers, Universitat Internacional de Catalunya, Barcelona, Spain. [Hernández S] VINCat Programme Surveillance of Healthcare Related Infections in Catalonia, Departament de Salut, Barcelona, Spain. [Grau S] Pharmacy Department, Infectious Diseases Service, Infectious Pathology and Antimicriobials Group (IPAR), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Hospital del Mar, Barcelona, Spain. [Padulles A] Pharmacy Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Barcelona, Spain. CIBER de Enfermedades Infecciosas (CIBERINFEC), ISC III, Madrid, Spain. [Boix-Palop L] Infectious Diseases Service, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. Medicine Department, Universitat Internacional de Catalunya, Barcelona, Spain
dc.contributor
Hospital General de Granollers
dc.contributor.author
Batlle, Maria
dc.contributor.author
Grau, Santiago
dc.contributor.author
Boix Palop, Lucía
dc.contributor.author
Hernández Baeza, Sergi
dc.contributor.author
Padullés-Zamora, Ariadna
dc.contributor.author
Badia, Josep M
dc.date.accessioned
2025-10-24T08:56:36Z
dc.date.available
2025-10-24T08:56:36Z
dc.date.issued
2024-03-05T07:39:17Z
dc.date.issued
2024-03-05T07:39:17Z
dc.identifier
Batlle M, Badia JM, Hernández S, Grau S, Padulles A, Boix-Palop L, et al. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. Int J Antimicrob Agents. 2023 Nov;62(5):106943.
dc.identifier
https://hdl.handle.net/11351/11155
dc.identifier
10.1016/j.ijantimicag.2023.106943
dc.identifier.uri
http://hdl.handle.net/11351/11155
dc.description.abstract
Anti-Bacterial Agents; Surgical Wound Infection; Infection Control
dc.description.abstract
Agentes Antibacterianos; Infección de Heridas Quirúrgicas; Control de la infección
dc.description.abstract
Agents antibacterians; Infecció de la ferida quirúrgica; Control de la infecció
dc.description.abstract
Background: Guidelines recommend 5-7 days of antibiotic treatment in patients with surgical infection and adequate source control. This nationwide stewardship intervention aimed to reduce the duration of treatments in surgical patients to <7 days.
Methods: Prospective cohort study evaluating surgical patients receiving antibiotics ≥7 days in 32 hospitals. Indication for treatment, quality of source control, type of recommendations issued, and adherence to the recommendations were analysed. Temporal trends in the percentages of patients with treatment >7 days were evaluated using a linear regression model and Pearson's correlation coefficients.
Results: A total of 32 499 patients were included. Of these, 13.7% had treatments ≥7 days. In all, 3912 stewardship interventions were performed, primarily in general surgery (90.7%) and urology (8.1%). The main types of infection were intra-abdominal (73.4%), skin/soft tissues (9.8%) and urinary (9.2%). The septic focus was considered controlled in 59.9% of cases. Out of 5458 antibiotic prescriptions, the most frequently analysed drugs were piperacillin/tazobactam (21.7%), metronidazole (11.2%), amoxicillin/clavulanate (10.3%), meropenem (10.7%), ceftriaxone (9.3%) and ciprofloxacin (6.7%). The main recommendations issued were: treatment discontinuation (35.0%), maintenance (40.0%) or de-escalation (15.5%), and the overall adherence rate was 91.5%. With adequate source control, the most frequent recommendation was to terminate treatment (51.2%). Throughout the study period, a significant decrease in the percentage of prolonged treatments was observed (Pc=-0.69;P < 0.001).
Conclusions: This stewardship programme reduced the duration of treatments in surgical departments. Preference was given to general surgery services, intra-abdominal infection, and beta-lactam antibiotics, including carbapenems. Adherence to the issued recommendations was high.
dc.format
application/pdf
dc.relation
International Journal of Antimicrobial Agents;62(5)
dc.relation
https://doi.org/10.1016/j.ijantimicag.2023.106943
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Medicaments antibacterians
dc.subject
Sales d'operacions
dc.subject
Infeccions quirúrgiques
dc.subject
CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents
dc.subject
DISEASES::Bacterial Infections and Mycoses::Infection::Wound Infection::Surgical Wound Infection
dc.subject
HEALTH CARE::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Control
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos
dc.subject
ENFERMEDADES::infecciones bacterianas y micosis::infección::infección de heridas::infección de la herida quirúrgica
dc.subject
ATENCIÓN DE SALUD::ambiente y salud pública::salud pública::práctica de la salud pública::control de enfermedades transmisibles::control de infecciones
dc.title
Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion